MARKET

STIM

STIM

Neuronetics
NASDAQ
3.780
+0.040
+1.07%
Opening 11:44 04/23 EDT
OPEN
3.750
PREV CLOSE
3.740
HIGH
4.170
LOW
3.750
VOLUME
21.41K
TURNOVER
0
52 WEEK HIGH
5.07
52 WEEK LOW
1.030
MARKET CAP
113.30M
P/E (TTM)
-3.5884
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at STIM last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at STIM last week (0408-0412)?
Weekly Report · 04/15 10:03
Neuronetics, Inc. Announces New Publication In Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Neuronetics, Inc. Published significant clinical findings in Brain Stimulation. Early symptom improvement in major depressive disorder (MDD) is strongly predictive of response at the completion of transcranial magnetic stimulation treatment. Researchers found that lack of early improvement does not predict final treatment outcome. The findings are based on research from the world's largest registry of depression outcomes.
Benzinga · 04/10 12:39
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Neuronetics, Inc. Published significant clinical findings in Brain Stimulation, the premier journal in the field of neuromodulation. Early symptom improvement in major depressive disorder does not predict final treatment outcome. Neuronetics is a medical technology company focused on neurohealth disorders.
Barchart · 04/10 07:31
Weekly Report: what happened at STIM last week (0401-0405)?
Weekly Report · 04/08 10:06
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
NASDAQ · 04/01 14:52
Weekly Report: what happened at STIM last week (0325-0329)?
Weekly Report · 04/01 10:05
Neuronetics Inc Shrinks Board Following Strategy Review
TipRanks · 03/28 20:27
More
About STIM
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.